Get the latest NAV of PGIM India Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹9.72
1D
NAV as on 16 May 2025
/per year
Since Inception
▲▼
74 people have invested ₹ 2.7L in PGIM India Healthcare Fund Direct Growth in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (16-May-25)
The fund has underperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (13-May-25)
Fund Distribution
as on (13-May-25)
Equity 95.1%
Debt & Cash 4.9%
See fund sector allocation details as on (13-May-25)
Sector Allocation
Equity 95.1%
Debt & Cash 4.9%
as on (30-Apr-25)
Equity
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 0.66% |
Benchmark | BSE Healthcare TR INR |
AUM | ₹108 Cr |
Inception Date | 6 December, 2024 |
Min Lumpsum/SIP | ₹5000/₹1000 |
Exit Load | 0.5% |
Lock In | No Lock-in |
TurnOver | 0% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
PGIM India Healthcare Fund Direct Growth is an equity fund. This fund was started on 6 December, 2024. The fund is managed by Puneet Pal, Anandha Padmanabhan Anjeneyan. The fund could potentially beat inflation in the long-run.
PGIM India Healthcare Fund Direct Growth has given a CAGR return of -2.80% since inception.
PGIM India Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Financial Services, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Max Healthcare Institute Ltd Ordinary Shares, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 1000.00. PGIM India Healthcare Fund Direct Growth has no lock in period.
Fund Manager of PGIM India Healthcare Fund Direct Growth, since 1 January 2025
Fund Manager of PGIM India Healthcare Fund Direct Growth, since 1 January 2025
5Y CAGR
▲ 33.08
5Y CAGR
▲ 26.46
5Y CAGR
▲ 21.55
3Y CAGR
▲ 17.37
PGIM India Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 2.42% | 2.42% |
6 Month Returns | 0% | 0% |
1 Year Returns | 0% | 0% |
3 Years Returns | 0% | 0% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
PGIM India Healthcare Fund Direct Growth | - | - | - |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
PGIM India Healthcare Fund Direct Growth | - | - | - |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
PGIM India Healthcare Fund Direct Growth | - | - | - |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
PGIM India Healthcare Fund Direct Growth | - | - | - |